All In Biotech

Drug Trial Radar · NCT07907783

Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

A Randomized, Multicenter, Double-Blind, Vehicle-Controlled, Phase 2 Study to Assess Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Nov 10, 2026

Primary completion

Sep 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Pelage Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Oct 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to evaluate safety and efficacy of PP405 in adult female participants with androgenetic alopecia

Conditions

  • Androgenetic Alopecia

Interventions

  • PP405 0.05% Topical GelDrug

    Medicated topical gel containing PP405 0.05%

  • Vehicle Topical GelDrug

    Topical gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in non-vellus target area hair countTime frame: Week 24

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas · Recruiting

  • DelRicht Research (Experience Dermatology)

    Atlanta, Georgia · Recruiting

  • Equity Medical, LLC

    New York, New York · Recruiting

  • DelRicht @Mt Pleasant Dermatology

    Mt. Pleasant, South Carolina · Recruiting

  • DelRicht Research @Harpeth Valley Dermatology

    Smyrna, Tennessee · Recruiting

  • Institution: Delricht Research @Lockhart

    Prosper, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.